| human | Q5 |
| P734 | family name | Bremer | Q16860394 |
| Bremer | Q16860394 | ||
| Bremer | Q16860394 | ||
| P106 | occupation | researcher | Q1650915 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q116213961 | A Universal Power-law Prescription for Variability from Synthetic Images of Black Hole Accretion Flows |
| Q53236337 | ATM missense variant P1054R predisposes to prostate cancer. |
| Q53590505 | Adjuvant radiotherapy in stage I seminoma: is there a role for further reduction of treatment volume? |
| Q84337349 | Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcome |
| Q44712404 | Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy |
| Q62583329 | Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy |
| Q62583339 | Association of two mutations in theCHEK2 gene with breast cancer |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q62583341 | Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy |
| Q40249058 | Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy |
| Q115593414 | Broadband Multi-wavelength Properties of M87 during the 2017 Event Horizon Telescope Campaign |
| Q116213960 | Characterizing and Mitigating Intraday Variability: Reconstructing Source Structure in Accreting Black Holes with mm-VLBI |
| Q80180923 | Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome |
| Q84637878 | Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis |
| Q47352811 | Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects |
| Q82639782 | Complete remission of a lymphoma-associated chylothorax by radiotherapy of the celiac trunk and thoracic duct |
| Q116213970 | Constraints on black-hole charges with the 2017 EHT observations of M87* |
| Q35880234 | Current status of selenium and other treatments for secondary lymphedema |
| Q34318753 | Distress, anxiety and depression in patients with brain metastases before and after radiotherapy |
| Q116213954 | Event Horizon Telescope imaging of the archetypal blazar 3C 279 at an extreme 20 microarcsecond resolution |
| Q116213944 | Event Horizon Telescope observations of the jet launching and collimation in Centaurus A |
| Q37307305 | Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls |
| Q40618684 | Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy |
| Q63087930 | First M87 Event Horizon Telescope Results. I. The Shadow of the Supermassive Black Hole |
| Q63087935 | First M87 Event Horizon Telescope Results. II. Array and Instrumentation |
| Q63087934 | First M87 Event Horizon Telescope Results. III. Data Processing and Calibration |
| Q63087932 | First M87 Event Horizon Telescope Results. IV. Imaging the Central Supermassive Black Hole |
| Q63087931 | First M87 Event Horizon Telescope Results. V. Physical Origin of the Asymmetric Ring |
| Q63088081 | First M87 Event Horizon Telescope Results. VI. The Shadow and Mass of the Central Black Hole |
| Q116213953 | First M87 Event Horizon Telescope Results. VII. Polarization of the Ring |
| Q116213951 | First M87 Event Horizon Telescope Results. VIII. Magnetic Field Structure near The Event Horizon |
| Q116213969 | First Sagittarius A* Event Horizon Telescope Results. I. The Shadow of the Supermassive Black Hole in the Center of the Milky Way |
| Q116213971 | First Sagittarius A* Event Horizon Telescope Results. II. EHT and Multiwavelength Observations, Data Processing, and Calibration |
| Q116213959 | First Sagittarius A* Event Horizon Telescope Results. III. Imaging of the Galactic Center Supermassive Black Hole |
| Q116213972 | First Sagittarius A* Event Horizon Telescope Results. IV. Variability, Morphology, and Black Hole Mass |
| Q116213966 | First Sagittarius A* Event Horizon Telescope Results. V. Testing Astrophysical Models of the Galactic Center Black Hole |
| Q116213973 | First Sagittarius A* Event Horizon Telescope Results. VI. Testing the Black Hole Metric |
| Q40564238 | Functional consequences of ATM sequence variants for chromosomal radiosensitivity |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q100676658 | Gravitational Test beyond the First Post-Newtonian Order with the Shadow of the M87 Black Hole |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q48553987 | Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach. |
| Q34457724 | Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach |
| Q84673439 | Image-guided hypofractionated small volume radiotherapy of non-small cell lung cancer - feasibility and clinical outcome |
| Q50119461 | Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy. |
| Q47953421 | Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors |
| Q43245943 | Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT). |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q27026534 | Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data |
| Q48714378 | Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy? |
| Q116213957 | Millimeter Light Curves of Sagittarius A* Observed during the 2017 Event Horizon Telescope Campaign |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q116213937 | Monitoring the Morphology of M87* in 2009–2017 with the Event Horizon Telescope |
| Q33320072 | Mutation analysis of the MDM4 gene in German breast cancer patients |
| Q51431905 | Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer. |
| Q62583334 | NBS1 variant I171V and breast cancer risk |
| Q43773075 | Nijmegen Breakage Syndrome mutations and risk of breast cancer |
| Q48323144 | Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience |
| Q35795253 | PALB2 mutations in German and Russian patients with bilateral breast cancer |
| Q53314322 | Partial-volume segmentation for dose optimization in whole-breast radiotherapy: a comparative dosimetric and clinical analysis. |
| Q85451905 | Pelvic radiotherapy after renal transplantation |
| Q113950528 | Polarimetric Properties of Event Horizon Telescope Targets from ALMA |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q33405523 | Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease |
| Q44242400 | Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe |
| Q51758096 | Radiation recall pneumonitis induced by gemcitabine. |
| Q38490549 | Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting |
| Q38970764 | Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots? |
| Q114023005 | Resolving the Inner Parsec of the Blazar J1924–2914 with the Event Horizon Telescope |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q116213965 | Selective Dynamical Imaging of Interferometric Data |
| Q46568833 | Self-reported cognitive outcomes in patients with brain metastases before and after radiation therapy |
| Q43813974 | TGFB1 gene polymorphism Leu10Pro (c.29T>C), prostate cancer incidence and quality of life in patients treated with brachytherapy |
| Q116213935 | THEMIS: A Parameter Estimation Framework for the Event Horizon Telescope |
| Q34408038 | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
| Q47138854 | Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients |
| Q116213946 | The Event Horizon General Relativistic Magnetohydrodynamic Code Comparison Project |
| Q116213938 | The Polarized Image of a Synchrotron-emitting Ring of Gas Orbiting a Black Hole |
| Q116213941 | The Variability of the Black Hole Image in M87 at the Dynamical Timescale |
| Q53361311 | The delineation of target volumes for radiotherapy of lung cancer patients. |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q116213936 | Verification of Radiative Transfer Schemes for the EHT |
| Q50744801 | Vestibular schwannoma microsurgery for recurrent tumors after radiation therapy or previous surgical resection. |
Search more.